A 3 Month Observational Prospective Patient Cohort Study of the Treatment of Breakthrough Pain in Cancer Patients With Instanyl.
Phase of Trial: Phase IV
Latest Information Update: 11 Aug 2013
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Acronyms INIS
- Sponsors Takeda Pharmaceuticals International GmbH
- 04 May 2012 Takeda Global Research and Development Center added as company and lead trial centre as reported by ClinicalTrials.gov.
- 29 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Jan 2010 New trial record